A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21629200
Conclusion of this study
L-carnitine therapy (50 mg/kilogram-bodyweight/day) administered for 3-months significantly improved several clinical measurements of ASD severity, but subsequent studies are recommended.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
